Other

Short-term debt

ResMed Short-term debt remained flat by 0.0% to $260.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2500.0%, from $10.00M to $260.00M. Over 3 years (FY 2022 to FY 2025), Short-term debt shows relatively stable performance with a 0.0% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ2 2022
Last reportedQ1 2026
Metric ID: other_short_term_debt_gross_5caa8b

Historical Data

16 periods
 Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$10.00M$10.00M$10.00M$10.00M$10.00M$10.00M$10.00M$10.00M$10.00M$10.00M$10.00M$10.00M$10.00M$260.00M$260.00M$260.00M
QoQ Change+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%>999%+0.0%+0.0%
YoY Change+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%>999%>999%>999%
Range$10.00M$260.00M
CAGR+138.4%
Avg YoY Growth+625.0%
Median YoY Growth+0.0%
Current Streak15+ quarters growth

Frequently Asked Questions

What is ResMed's short-term debt?
ResMed (RMD) reported short-term debt of $260.00M in Q1 2026.
How has ResMed's short-term debt changed year-over-year?
ResMed's short-term debt increased by 2500.0% year-over-year, from $10.00M to $260.00M.
What is the long-term trend for ResMed's short-term debt?
Over 3 years (2022 to 2025), ResMed's short-term debt has grown at a 0.0% compound annual growth rate (CAGR), from $10.00M to $10.00M.